Study finds low-dose aspirin may increase risk of anemia in older adults

LOS ANGELES, June 20 (Xinhua) -- Daily low-dose aspirin increases the risk of anemia in people aged 65 years and older by approximately 20 percent, according to data of a clinical trial funded by the U.S. National Institutes of Health (NIH).

Anemia in older adults is associated with functional decline, increased fatigue, disabilities, depressive symptoms, and cognition problems.